查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1624577

中東和非洲的安瓿包裝：市場佔有率分析、產業趨勢和成長預測（2025-2030）

MEA Ampoules Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

中東和非洲安瓿包裝市場規模預計到 2025 年為 16.6 億美元，預計到 2030 年將達到 19.7 億美元，預測期內（2025-2030 年）年複合成長率為 3.5%。

MEA安瓿包裝-市場-IMG1

製藥業的成長正在推動市場的成長。該地區的藥品產量不斷增加，對安瓿的需求也隨之增加。

主要亮點

  • 中東和非洲地區的製藥業發展潛力巨大，為安瓿製造商提供了許多機會。此外，地方政府透過長期計畫的持續支持和投資，支持醫藥產業的永續發展。
  • 《杜拜 2030 年工業戰略》和《阿布達比 2030 年願景》將製藥業視為具有巨大成長潛力的產業。 《杜拜2030年工業戰略》和《阿布達比2030年願景》將製藥業確定為具有巨大成長潛力的產業，製藥業的成長前景、出口潛力和中長期經濟影響顯示我們的目標是實現重大發展。
  • 該行業正在不斷發展，需要包裝來治療傳染性和非傳染性疾病。因此，藥品生產對安瓿包裝的需求不斷增加，以保護藥品免受損壞、生物污染和外部影響。
  • 非洲擁有臨床試驗基礎設施和能力，其中大部分位於南非。因為南非在研發方面的投資比非洲大陸其他地區都多。 Ardagh 集團的非洲分公司 Ardagh Glass Packaging-Africa (AGP-Africa) 宣布投資擴大其位於南非豪登省 Nigel 工廠的生產能力。為了滿足未來幾年的預期需求，該公司將擴大其設施，增加第三座熔爐，以實現永續玻璃包裝的生產。
  • 為了提高國產藥品的品質和完整性，政府推出了嚴格的規則和法規，導致玻璃作為藥品包裝產品材料的使用增加。由於它們對環境產生負面影響，各國政府和監管機構已禁止和限制在藥品包裝中使用某些類型的塑膠，例如一次性塑膠和某些非再生塑膠。

中東和非洲安瓿包裝市場趨勢

玻璃安瓿的採用預計將變得引人注目。

  • 玻璃安瓿因其各種優點（包括 100%詐欺包裝）而廣泛應用於製藥業作為注射藥物的初級包裝。安瓿也是注射藥物初級包裝的熱門選擇，並在中東和非洲等成本敏感的新興市場中廣泛採用。
  • 該地區政府正在加強和支持，以促進學名藥的採用以及學名藥商店的建立。該地區感染疾病爆發的高發生率將推動注射劑的採用，並預計在預測期內增加玻璃安瓿的採用。根據 Alpen Capital 的數據，2022 年醫療保健支出將為 607 億美元，2023 年將增加至 638 億美元。醫療保健支出的增加將推動市場成長。
  • 對於愛滋病毒/愛滋病等疾病的治療，越來越需要無菌注射藥物設備來注射藥物，因為使用同一設備注射藥物很容易發生感染。安瓿有時也用於儲存和運輸藥物。由於該地區愛滋病毒/愛滋病的高風險，玻璃安瓿的使用預計會增加。
  • 阿拉伯聯合大公國（UAE）擁有最發達的醫藥市場之一和強大的醫療基礎設施。阿拉伯聯合大公國國內藥品製造商正在增加藥品產量。輝瑞、諾華、葛蘭素史克 (GSK)、默克、艾伯維、禮來、拜耳、阿斯特捷利康、賽諾菲、百時美施貴寶和安進等大型製藥企業和跨國公司長期以來透過製造和當地銷售管道建立了影響力。
  • 沙烏地阿拉伯國家工業發展與物流計畫（NDLP）預計，到2030年，沙烏地阿拉伯的製藥業務將價值440億沙烏地裡亞爾（約117.2億美元）。根據ITA估計，2022年醫療保健和社會發展支出預計為368億美元，佔總預算的14.4%，是繼教育和軍事之後的第三大類別。醫療保健產業私有化是沙烏地阿拉伯政府的目標。成長機會的增加將為各種玻璃安瓿包裝公司投資該領域創造機會。

南非預計將佔有很大佔有率

  • 由於相對穩定的政治氣候和來自世界各地的企業的大量投資，南非的經濟正在蓬勃發展。該國的製藥業也在顯著成長。
  • 南非製藥業的快速成長得益於快速的都市化、醫療保健支出的增加以及主要企業投資的增加。鼓勵國際參與者擴大在南非製藥業的影響力。 Aspen Pharmacare 等公司正在見證成長，2023 年估值為 22.0561 億美元，2020 年估值為 18.236 億美元。這種收益成長預計將提振安瓿市場。
  • 隨著南非製藥業的快速發展，對合適的包裝解決方案的需求也不斷成長。這是因為藥品在藥品供應鏈中從製造到消費的各個過程中都必須小心處理。這主要是由於藥物的敏感性，暴露在外在環境中就失去了治療效果和藥效。因此，製藥公司必須遵守嚴格的消費者安全和環境法規。
  • 由於疾病發病率的上升以及對維持醫療解決方案免受外部環境影響的需求不斷成長，製藥公司在製造、儲存和包裝的每個階段都在確保藥品的品質。此外，製藥公司正在推出治療該國流行的重大疾病的藥物，進一步增加了南非對安瓿的需求。
  • 在收入水平提高、環保意識增強、有利的人口趨勢以及向單向包裝的轉變等多種因素的推動下，非洲對永續包裝的需求正在顯著增加。
  • 根據非洲大陸自由貿易區（AfCFTA）私部門策略，非洲大陸40%的疾病和殘疾是由愛滋病毒/愛滋病、結核病、瘧疾、腹瀉和呼吸道疾病引起的，所有這些疾病都可以透過包裝藥物治療。的是這可能為該國安瓿等醫藥包裝產品創造商機。

中東和非洲安瓿包裝產業概況

玻璃安瓿高度透明，易於檢查和監控內容物。隨著製藥業的擴張，對玻璃安瓿的需求也不斷成長。隨著生產水準的提高，該地區對藥用玻璃產品的需求正在迅速增加。

由於康寧公司、3M公司、肖特公司、格雷斯海默公司和尼普羅公司等主要企業很少，市場變得整合。市場參與者正在努力與多個區域組織建立重要合作，以擴大其在市場中的影響力和佔有率。該地區製藥業的市場發展預計將為現有參與者和新進入者提供機會。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場洞察

  • 市場概況
  • 產業價值鏈分析
  • 產業吸引力－波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度

第5章市場動態

  • 市場促進因素
    • 對安全可靠的藥品包裝的需求不斷成長
    • 增加政府對包裝材料的法規
  • 市場限制因素
    • 環境和永續性議題

第6章 市場細分

  • 材料
    • 玻璃
    • 塑膠
  • 國家名稱
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 埃及

第7章 競爭格局

  • 公司簡介
    • SCHOTT AG
    • Corning Incorporated
    • 3M Company
    • Gerresheimer AG
    • Nurrin Pharmalab Pty（Ltd）
    • Yadong Pharma Packaging Industry Co. Ltd
    • Nipro Corporation

第8章投資分析

第9章 市場機會及未來趨勢

簡介目錄
Product Code: 46310

The MEA Ampoules Packaging Market size is estimated at USD 1.66 billion in 2025, and is expected to reach USD 1.97 billion by 2030, at a CAGR of 3.5% during the forecast period (2025-2030).

MEA Ampoules Packaging - Market - IMG1

The growing pharmaceutical industry is helping the market grow. The need for ampoules increases with the increasing pharmaceutical production in the region.

Key Highlights

  • Middle East and Africa has enormous potential for the pharmaceutical industry's growth, posing several opportunities for ampoule manufacturers. Additionally, the regional government supports the pharmaceutical industry's sustainable development through continued support and investments in long-term plans.
  • The Dubai Industrial Strategy 2030 and the Abu Dhabi Vision 2030 view the pharmaceutical industry as one with major growth potential. They aim to make significant developments due to the growth prospects, export potential, and mid-term to long-term economic impact of the industry.
  • The industry is growing, and there is a need for packaging to heal communicable and non-communicable diseases. Thus, the demand for ampoule packaging in pharmaceutical manufacturing is increasing as it protects pharmaceuticals from damage, biological contamination, and external influences.
  • Africa has clinical trial infrastructure and capabilities, most of which are in South Africa, as it has invested more heavily in R&D than others on the continent. The African business division of Ardagh Group, Ardagh Glass Packaging - Africa (AGP - Africa), announced an investment to expand the manufacturing capacity of its Nigel factory in Gauteng, South Africa. To satisfy anticipated demand over the coming years, the company will expand its facility by adding a third furnace, enabling it to produce sustainable glass packaging.
  • Introducing stringent rules and regulations to improve the quality and integrity of domestically manufactured drugs increases the usage of glass as a material for pharmaceutical packaging products. Due to adverse environmental impact, governments and regulatory bodies have introduced bans or restrictions on several specific types of plastics used for pharmaceutical packaging, such as single-use plastics or certain non-recycled plastics.

MEA Ampoules Packaging Market Trends

Glass Ampoules Are Expected to Witness Significant Adoption

  • Glass ampoules are widely adopted as a type of primary packaging in the pharmaceutical industry for injection drugs due to their various benefits, such as 100% tamper-proof packaging. Also, ampoules are a popular choice for primary packaging for injectables and are widely adopted in cost-sensitive or emerging markets like Middle East and Africa.
  • The region is witnessing an increase in government initiatives and support to foster the adoption of generic products, coupled with the move to start generic medical stores. The high prevalence of infectious diseases in the region is expected to drive the adoption of injectables, increasing the adoption of glass ampoules during the forecast period. According to Alpen Capital, the healthcare expenditure was USD 60.7 billion in 2022, which increased to USD 63.8 billion in 2023. Such increases in healthcare expenditures drive the market's growth.
  • In the case of diseases like HIV/AIDS treatment, the need for sterile drug injection equipment for injecting drugs increases, as the disease can easily be transmitted by using the same equipment to inject the drug. Hence, ampoules may be used for drug storage and transport. This is expected to increase the adoption of glass ampoules in the region, as the risk of HIV/AIDS is high.
  • The UAE pharmaceutical market is one of the most developed and has a robust healthcare infrastructure. Domestic medication manufacturers in the United Arab Emirates have increased their production of medicines. With their long-standing presence in the nation through manufacturing or local distribution channels, major research-based pharmaceutical companies and top multi-nationals, like Pfizer, Novartis, GlaxoSmithKline (GSK), Merck, AbbVie, Eli Lily, Bayer, AstraZeneca, Sanofi, BMS, and Amgen, have opened up opportunities for market growth.
  • The Saudi National Industrial Development and Logistics Program (NDLP) estimates that Saudi Arabia's pharmaceutical business will be worth SAR 44 billion (USD 11.72 billion approximately) by 2030. According to ITA, healthcare and social development were estimated to be valued at USD 36.8 billion in 2022, or 14.4% of its overall budget, and the third-largest category after education and the military. Privatizing the healthcare sector is a goal of the Saudi Arabian government. The increase in growth would create opportunities for various glass ampoule packaging companies to invest in the sector.

South Africa Expected to Hold a Significant Share

  • South Africa's economy is booming due to a relatively stable political scenario and the enormous investments made by companies worldwide. The country has also seen significant growth in the pharmaceutical industry.
  • The rapid growth in the pharmaceutical industry in South Africa can be attributed to rapid urbanization, an increase in healthcare spending, and a rise in investments by leading pharmaceutical companies. International players are encouraged to expand their presence in the pharmaceutical landscape of South Africa. Companies such as Aspen Pharmacare are witnessing growth; it was valued at USD 2205.61 million in 2023 and USD 1823.6 million in 2020. Such revenue growth would leverage the market for ampoules.
  • With rapid growth in the pharmaceutical industry in South Africa, the need for proper packaging solutions also increases. This is because during the various processes in the supply chain of a pharmaceutical product, starting from manufacture to consumption, the pharmaceutical products need to be handled carefully. This is mainly due to the sensitivity of narcotics, which lose their therapeutic or medicinal properties when exposed to any exterior environment. Hence, pharmaceutical companies must follow stringent consumer safety and environmental regulations.
  • Due to the growing number of diseases and the growing need to keep medical solutions safe from the external environment, pharmaceutical companies ensure the quality of pharmaceuticals throughout the manufacturing, storing, and packaging processes. Also, pharmaceutical companies are launching drugs to treat major diseases prevalent in the country, further boosting the demand for ampoules in South Africa.
  • Africa is experiencing a significant increase in the need for sustainable packaging, fueled by several factors, including rising income levels, growing environmental consciousness, favorable demographics, and a move toward one-way packaging.
  • According to the African Continental Free Trade Area (AfCFTA) Private Sector Strategy, 40% of the disease hindrance on the continent is due to HIV/AIDS, tuberculosis, malaria, diarrhea, and respiratory diseases, all of which are commonly treated by packaged medicines. This might create opportunities for pharmaceutical packaging products, including ampoules, in the country.

MEA Ampoules Packaging Industry Overview

Glass ampoules offer superior transparency, facilitating effortless inspection and monitoring of their contents. As the pharmaceutical industry expands, it fuels the demand for glass ampoules. The region is witnessing a surge in demand for these pharmaceutical glass products, driven by escalating production levels.

The market is consolidated due to very few major players, such as Corning Incorporated, 3M Company, Schott AG, Gerresheimer AG, and Nipro Corporation. The market players strive to create significant collaborations with several regional organizations to expand their market presence and share. Developments in the pharmaceutical industry in the region are expected to provide opportunities for the existing as well as new market players.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Safe and Reliable Pharmaceutical Packaging
    • 5.1.2 Increasing Government Mandates Regarding Packaging Material
  • 5.2 Market Restraints
    • 5.2.1 Environmental and Sustainability Issues

6 MARKET SEGMENTATION

  • 6.1 Material
    • 6.1.1 Glass
    • 6.1.2 Plastic
  • 6.2 Country
    • 6.2.1 Saudi Arabia
    • 6.2.2 United Arab Emirates
    • 6.2.3 South Africa
    • 6.2.4 Egypt

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 SCHOTT AG
    • 7.1.2 Corning Incorporated
    • 7.1.3 3M Company
    • 7.1.4 Gerresheimer AG
    • 7.1.5 Nurrin Pharmalab Pty (Ltd)
    • 7.1.6 Yadong Pharma Packaging Industry Co. Ltd
    • 7.1.7 Nipro Corporation

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS